SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-151456
Filing Date
2019-05-20
Accepted
2019-05-20 13:18:56
Documents
3
Group Members
TAKEDA PHARMACEUTICALS INTERNATIONAL AGTAKEDA PHARMACEUTICALS U.S.A., INC.TAKEDA VENTURES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d751640dsc13g.htm SC 13G 85388
2 EX-99.1 d751640dex991.htm EX-99.1 1178
3 EX-99.2 d751640dex992.htm EX-99.2 7681
  Complete submission text file 0001193125-19-151456.txt   95875
Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Subject) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91007 | Film No.: 19838132
SIC: 2836 Biological Products, (No Diagnostic Substances)